The differential effect was largely driven by the findings from the Beta-Blocker Evaluation of Survival (BEST) trial, which reported a nominally significant interaction indicating increased mortality among Black participants.
← all excerpts
Clinical outcomes of pharmacological therapies for heart failure in Black vs. White populations: a meta-analysis of randomized controlled trials of heart failure treatment.
1
—
—